Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 20 Polycystic Ovary Syndrome 10 Prostatic Neoplasms 7 Breast Neoplasms 6 Neoplasms 5 Colorectal Neoplasms 4 Insulin Resistance 3 Lung Neoplasms 2 Fatigue 2 Esophageal Neoplasms 2 Cardiotoxicity 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Primary Dysautonomias 1 Pediatric Brain Tumor 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Follicular 1 Lupus Erythematosus, Systemic 1 Inflammation 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Disease 1 Diabetes Mellitus, Type 1 1 Chemotherapy-Related Cognitive Impairment 1 Cardiovascular Diseases 1

Interventions

Temozolomide 162 Radiosurgery 114 Radiotherapy 99 Bevacizumab 95 Magnetic Resonance Spectroscopy 64 Carboplatin 48 Etoposide 34 Surgical Procedures, Operative 33 Irinotecan 33 pembrolizumab 32 Nivolumab 32 Cyclophosphamide 32 Erlotinib Hydrochloride 31 Radiation 29 Carmustine 28 Cisplatin 25 Lomustine 24 Trastuzumab 23 Ipilimumab 23 Filgrastim 23 Vincristine 20 Mental Status and Dementia Tests 20 Aminolevulinic Acid 19 Topotecan 18 Pemetrexed 18 Capecitabine 18 Specimen Handling 17 Sorafenib 15 Radiotherapy, Intensity-Modulated 15 Imatinib Mesylate 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Brain Neoplasms × High-Intensity Interval Training × Clear all

NCT06282562 2025-04-06

FeelFit

Amsterdam UMC, location VUmc

Phase NA Recruiting

Brain Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡